97 related articles for article (PubMed ID: 6774883)
1. Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma.
Hollmann KH; Verley JM
Experientia; 1980 Oct; 36(10):1213-5. PubMed ID: 6774883
[TBL] [Abstract][Full Text] [Related]
2. The influence of dietary fat and non-specific immunotherapy on carcinogen-induced rat mammary adenocarcinoma.
Kollmorgen GM; King MM; Roszel JF; Daggs BJ; Longley RE
Vet Pathol; 1981 Jan; 18(1):82-91. PubMed ID: 6781126
[TBL] [Abstract][Full Text] [Related]
3. Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapy.
Chen WR; Jeong SW; Lucroy MD; Wolf RF; Howard EW; Liu H; Nordquist RE
Int J Cancer; 2003 Dec; 107(6):1053-7. PubMed ID: 14601069
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
6. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure.
Baum A; Mevissen M; Kamino K; Mohr U; Löscher W
Carcinogenesis; 1995 Jan; 16(1):119-25. PubMed ID: 7834796
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy, chemically-induced mammary tumors and parathymic lymph nodes in rats: experimental and morphological studies.
Ben-Hur H; Kossoy G; Lifschitz O; Zusman I
In Vivo; 2002; 16(4):275-80. PubMed ID: 12224138
[TBL] [Abstract][Full Text] [Related]
8. Immunological investigation and immunotherapy in patients operated on for breast carcinoma.
Reynier J; Villet R; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM
Int Surg; 1982; 67(1):17-24. PubMed ID: 7095998
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
10. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
11. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis.
Welsch CW; DeHoog JV; O'Connor DH
Cancer Res; 1988 Apr; 48(8):2068-73. PubMed ID: 3127044
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
13. Apparent rat strain-related sensitivity to phorbol promotion of mammary carcinogenesis.
Shellabarger CJ; Holtzman S; Stone JP
Cancer Res; 1979 Sep; 39(9):3345-8. PubMed ID: 113089
[TBL] [Abstract][Full Text] [Related]
14. Adrenal regulation of mammary tumorigenesis in female Sprague-Dawley rats: histopathology of mammary tumors.
Carter JH; Carter HW
Cancer Res; 1988 Jul; 48(13):3808-15. PubMed ID: 3132321
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral TNFalpha administration influences tumour stroma structure and physiology independently of growth in DMBA-induced mammary tumours.
Stuhr LE; Moen I; Nedrebø T; Salnikov AV; Wiig H; Rubin K; Reed RK
Scand J Clin Lab Invest; 2008; 68(7):602-11. PubMed ID: 19378432
[TBL] [Abstract][Full Text] [Related]
16. Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats.
Rajakumar T; Pugalendhi P; Thilagavathi S
Chem Biol Interact; 2015 Apr; 231():35-43. PubMed ID: 25744308
[TBL] [Abstract][Full Text] [Related]
17. Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.
Welsch CW; DeHoog JV
Cancer Res; 1983 Feb; 43(2):585-91. PubMed ID: 6401220
[TBL] [Abstract][Full Text] [Related]
18. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
Shan L; He M; Yu M; Qiu C; Lee NH; Liu ET; Snyderwine EG
Carcinogenesis; 2002 Oct; 23(10):1561-8. PubMed ID: 12376462
[TBL] [Abstract][Full Text] [Related]
19. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
Iino Y; Takai Y; Sugamata N; Morishita Y
Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats.
Karnam KC; Ellutla M; Bodduluru LN; Kasala ER; Uppulapu SK; Kalyankumarraju M; Lahkar M
Biomed Pharmacother; 2017 Aug; 92():207-214. PubMed ID: 28544934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
